Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality?

Autor: Madioko Makanzu B; Department of Cardiology, Kinshasa University Hospital, Kinshasa, DR Congo, Kinshasa University Hospital, Kinshasa 11, Congo. bmaknzu@gmail.com., Makulo JR; Nephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo, Kinshasa 11, Kinshasa, Congo., Ndona Mandina M; Department of Infectious Diseases, Kinshasa University Hospital, Kinshasa, DR Congo, Kinshasa 11, Congo., Wumba DR; Department of Tropical Medicine, University of Kinshasa, Kinshasa 11, Congo., Mashi Longokolo M; Department of Infectious Diseases, University of Kinshasa Hospital, Kinshasa 11, Congo., Situakibanza H; Department of Tropical Medicine and Infectious Disease, School of Medicine, University of Kinshasa, Kinshasa 11, Congo., Odio O; Department of Infectious Diseases, Kinshasa University Hospital, Kinshasa, DR Congo, Kinshasa 11, Congo., Sonzi Mangala D; COVID-19 Treatment Center, Kinshasa University Hospital, Kinshasa, Kinshasa 11, Congo., Mihigo Bashengezi C; Centre de Recherche en Phytothérapie, Pharmacopée Africaine et Technologie pharmaceutique, Kinshasa 11, Congo., Kabwe Mwilambwe B; Intensive Care Unit, Kinshasa University Hospital, Kinshasa 11, Congo., Kabanda Kurhenga G; Department of Cardiology, Kinshasa University Hospital, Kinshasa, DR Congo, Kinshasa University Hospital, Kinshasa 11, Congo., Longo-Mbenza B; Department of Cardiology, Kinshasa University Hospital, Kinshasa, DR Congo, Kinshasa University Hospital, Kinshasa 11, Congo., Mwimba Mbungu R; Department of Gynecology and Obstetrics, Kinshasa University Hospital, Kinshasa 11, Congo.

Publikováno v: World journal of virology [World J Virol] 2024 Jun 25; Vol. 13 (2), pp. 90668.